NMS Capital has exited its investment in Flourish Research, a US-based clinical trial organization, through a sale to Genstar Capital. No financial terms were disclosed.
Original research ranges from new concepts in human biology and disease pathogenesis to new therapeutic modalities and drug development, to all phases of clinical work, as well as innovative ...
According to Arizton’s latest research report, the global clinical trials software market is growing at a CAGR of 16.40% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback